Pictured above is Dr. Ram Rohatgi, Jr. a Mayo Clinic pediatric cardiology fellow and first author of the study discussed in the article referenced below. This story was originally written by Brett Boese and published by the Post Bulletin.
There is renewed hope for patients suffering from a potentially-fatal heart rhythm condition known as long QT syndrome. According to a study published in the Journal of the American College of Cardiology by Mayo Clinic researchers, patients with diagnosed and treated genetic heart rhythm syndromes are much less likely to have severe events, such as fainting, seizures, and sudden cardiac death, than previous thought.
This 16-year, groundbreaking study showed that only 8 percent of the 606 patients studied experienced symptoms after treatment. According to Dr. Rohatgi, this may be partly due to earlier recognition and treatment of the disease.
Read the full article here.